Difference between revisions of "Alpha-methylacyl-CoA racemase"

From Libre Pathology
Jump to navigation Jump to search
Line 7: Line 7:
==Positive or negative==
==Positive or negative==
*[[Nephrogenic adenoma]].
*[[Nephrogenic adenoma]].
*[[Urothelial carcinoma]] - not useful for differentating ''prostate'' versus ''bladder''.


==Negative==
==Negative==

Revision as of 16:38, 11 December 2014

Alpha-methylacyl-CoA racemase, abbreviated AMACR, is a commonly used immunostain in genitourinary pathology.

Positive

Positive or negative

Negative

See also

References

  1. Lloyd, MD.; Yevglevskis, M.; Lee, GL.; Wood, PJ.; Threadgill, MD.; Woodman, TJ. (Apr 2013). "α-Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S.". Prog Lipid Res 52 (2): 220-30. doi:10.1016/j.plipres.2013.01.001. PMID 23376124.
  2. Molinié, V.; Balaton, A.; Rotman, S.; Mansouri, D.; De Pinieux, I.; Homsi, T.; Guillou, L. (Jun 2006). "Alpha-methyl CoA racemase expression in renal cell carcinomas.". Hum Pathol 37 (6): 698-703. doi:10.1016/j.humpath.2006.01.012. PMID 16733210.